Clearline Capital’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.5M Sell
212,466
-71,754
-25% -$10.4M 2.06% 15
2026
Q1
$33.6M Sell
284,220
-38,149
-12% -$5.01M 1.74% 11
2025
Q4
$38.4M Buy
322,369
+87,997
+38% +$10M 1.89% 11
2025
Q3
$23.5M Buy
234,372
+99,406
+74% +$11.8M 1.08% 13
2025
Q2
$17.4M Buy
134,966
+1,100
+0.8% +$134K 0.65% 23
2025
Q1
$17.1M Buy
+133,866
New +$19.2M 1.03% 21
2024
Q3
Sell
-11,497
Closed -$1.88M 160
2024
Q2
$1.88M Buy
11,497
+4,778
+71% +$775K 0.05% 94
2024
Q1
$1.17M Buy
+6,719
New +$1.1M 0.06% 99

Other funds holding NOVT

Clearline Capital's NOVT Position: Q2 2026 in Review

Clearline Capital reduced its Novanta (NOVT) stake by 25% in Q2 2026, selling an estimated $10.4M and leaving 212,466 shares worth $34.5M. The position accounts for 2.06% of the portfolio, ranked #15.

Clearline Capital first reported a position in NOVT in Q1 2024 and has held it in 8 quarters since. The position peaked at $38.4M in Q4 2025. 390 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Clearline Capital held 212,466 shares of Novanta worth $34.5M as of Q2 2026.
  • Clearline Capital sold 71,754 Novanta shares in Q2 2026, an estimated $10.4M.
  • Novanta made up 2.06% of Clearline Capital's portfolio in Q2 2026, its #15 holding.
  • Clearline Capital first reported a position in Novanta in Q1 2024 and has held it in 8 quarters since.
  • Clearline Capital's Novanta position peaked at $38.4M in Q4 2025.
  • 390 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Clearline Capital's 13F filing for Q2 2026, filed 14 Aug 2026.